Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,057 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
Tanigawa T, Takeshima N, Ishikawa H, Nishio S, Usami T, Yamawaki T, Oishi T, Ihira K, Kato H, Goto M, Saito M, Taira Y, Yokoyama M, Shoji T, Kondo E, Mori A, Yokoi T, Iwasa-Inoue N, Hirashima Y, Nagasawa T, Takenaka M, Mikami M, Sugiyama T, Enomoto T. Tanigawa T, et al. Among authors: takenaka m. Gynecol Oncol. 2022 Jun;165(3):413-419. doi: 10.1016/j.ygyno.2022.04.011. Epub 2022 Apr 27. Gynecol Oncol. 2022. PMID: 35487773 Clinical Trial.
Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey study.
Nishio S, Murotani K, Nakao S, Takenaka M, Suzuki S, Aoki Y, Todo Y, Hosaka M, Nakai H, Katabuchi H, Nishi H, Takekuma M, Mikami M, Enomoto T. Nishio S, et al. Among authors: takenaka m. Gynecol Oncol. 2020 Nov;159(2):449-455. doi: 10.1016/j.ygyno.2020.08.019. Epub 2020 Aug 25. Gynecol Oncol. 2020. PMID: 32854973
Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study.
Iihara H, Shimokawa M, Hayasaki Y, Fujita Y, Abe M, Takenaka M, Yamamoto S, Arai T, Sakurai M, Mori M, Nakamura K, Kado N, Murase S, Shimaoka R, Suzuki A, Morishige KI. Iihara H, et al. Among authors: takenaka m. Gynecol Oncol. 2020 Mar;156(3):629-635. doi: 10.1016/j.ygyno.2020.01.004. Epub 2020 Jan 9. Gynecol Oncol. 2020. PMID: 31926638 Free article. Clinical Trial.
Iron regulatory protein 2 in ovarian endometrial cysts.
Takenaka M, Suzuki N, Mori M, Hirayama T, Nagasawa H, Morishige KI. Takenaka M, et al. Biochem Biophys Res Commun. 2017 Jun 10;487(4):789-794. doi: 10.1016/j.bbrc.2017.04.115. Epub 2017 Apr 25. Biochem Biophys Res Commun. 2017. PMID: 28450115
[Promotion of Equal Access to Medical Services for Children, Adolescent and Young Adult(CAYA)Cancer Patients with Reproductive Problems-A Nationwide Expansion of the Regional Oncofertility Network in Japan].
Takenaka M, Furui T, Takae S, Sugishita Y, Kawahara T, Shigematsu K, Kimura F, Horie A, Hara T, Kato M, Nishiyama H, Suzuki T, Miyachi M, Kanenishi K, Kubo K, Nakayama S, Kajiyama H, Takai Y, Suzuki N. Takenaka M, et al. Gan To Kagaku Ryoho. 2020 Dec;47(12):1691-1696. Gan To Kagaku Ryoho. 2020. PMID: 33342985 Japanese.
1,057 results